Quercetin alleviates imatinib-induced premature ovarian insufficiency by regulating mitophagy via the ROS/JNK/c-JUN pathway
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116405 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Qing-Hui Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Quercetin, Primary Ovarian Insufficiency, Imatinib Mesylate. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Imatinib (IMA), a first-line tyrosine kinase inhibitor for hematologic neoplasms, has been demonstrated to potentially contribute to ovarian dysfunction and potential fertility impairment in premenopausal women following extended therapeutic regimens. As a bioactive flavonoid, quercetin (QUE) possesses diverse therapeutic effects, such as reducing oxidative stress, suppressing inflammation, and delaying aging. In our previous study, we demonstrated that QUE may mitigate IMA-induced ovarian damage, although the specific mechanism remained unclear. In this study, we employed an integrated approach combining network pharmacology with in vivo and in vitro experiments to demonstrate whether IMA induces excessive oxidative stress and mitophagy in ovarian granulosa cells, and further determine whether QUE exerts its protective effects through this pathway. We observed that IMA elevated levels of intracellular reactive oxygen species and mitochondrial superoxide, reduced mitochondrial membrane potential, and enhanced apoptosis in KGN cells. In addition, IMA induced the expression of mitophagy (Pink1 and Parkin) and autophagy (ATG5, P62, and LC3B) flow-related proteins in mice ovaries and KGN cells. Finally, we discovered that IMA activated the expression of p-JNK and c-JUN in both mice ovaries and KGN cells, while inhibited the phosphorylation of mTOR. QUE, reactive oxygen species inhibitor (N-Acetylcysteine) and JNK inhibitor (SP600125) played a restorative role to some extent. Our study establishes a theoretical foundation for the application of natural products in fertility preservation therapy for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
- Department of Assisted Reproduction, Maternity and Child Health Hospital of Jiujiang, Jiujiang, Jiangxi 332000, China.
- School of Pharmacy, Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, Nanchang 330031, China. Electronic address: luotao@ncu.edu.cn.
- Reproductive Medicine Center, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Electronic address: lzxia77@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, Q. H., Ji, M., Weng, S. Q., Li, X., Xiao, Q., Zhou, Y., Luo, T., & Liu, Z. X. (2026). Quercetin alleviates imatinib-induced premature ovarian insufficiency by regulating mitophagy via the ROS/JNK/c-JUN pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116405
Vancouver
Li QH, Ji M, Weng SQ, Li X, Xiao Q, Zhou Y, et al. Quercetin alleviates imatinib-induced premature ovarian insufficiency by regulating mitophagy via the ROS/JNK/c-JUN pathway. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116405
BibTeX
@article{Li2026,
author = {Li, Qing-Hui and Ji, Min and Weng, Shi-Qi and Li, Xia and Xiao, Qin and Zhou, Yan and Luo, Tao and Liu, Zhao-Xia},
title = {Quercetin alleviates imatinib-induced premature ovarian insufficiency by regulating mitophagy via the ROS/JNK/c-JUN pathway},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116405}
}
EUVIMED